| Name | NALCN antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe collection of studies summarized here provides extensive insights into the roles of cysteinyl leukotrienes and their receptors – particularly CysLT1R and CysLT2R – in mediating inflammatory responses across multiple organ systems. These works demonstrate that leukotrienes regulate a spectrum of processes including mast cell proliferation, endothelial permeability, platelet activation, and immune cell recruitment in conditions such as allergic asthma, atopic dermatitis, ischemia‐reperfusion injury, neurotoxicity, and diabetic or ischemic retinopathy. Notably, however, none of these studies address or mention the function of NALCN‐AS1, leaving its role in these inflammatory and immunologic contexts unexplored."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nFurther detailed investigations reveal that activation of specific leukotriene receptors – such as the selective LTC4 engagement of CysLT2R on platelets or dendritic cells – influences downstream mediators, ranging from IL‑33 production and mast cell degranulation to modulation of ERK phosphorylation and collagen deposition. These mechanisms have been implicated in amplifying type 2 immunopathology, promoting airway remodeling in allergic settings, and even modulating neuronal excitability. Despite the breadth of these findings, the literature currently provides no evidence linking NALCN‑AS1 to any of these regulatory cascades, indicating a significant gap in our understanding of its potential role relative to leukotriene‑mediated signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "10"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, while the highlighted abstracts collectively enhance our understanding of leukotriene receptor signaling and its implications for inflammatory disease pathogenesis, they do not elucidate any functional role for NALCN‑AS1. This absence suggests that NALCN‑AS1 remains an uncharacterized element with respect to these immunological and inflammatory processes. Future investigations will be necessary to determine whether NALCN‑AS1 has regulatory interactions with leukotriene pathways or if it contributes to alternative cellular functions beyond those described in the current body of research"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "16"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wen-Wen Sheng, Cheng-Tan Li, Wei-Ping Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.05.023"}], "href": "https://doi.org/10.1016/j.bbrc.2006.05.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16756959"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16756959"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yongfeng Jiang, Laura A Borrelli, Yoshihide Kanaoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-07-100453"}], "href": "https://doi.org/10.1182/blood-2007-07-100453"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17693579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17693579"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wei Jiang, Sean R Hall, Michael P W Moos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2008.070834"}], "href": "https://doi.org/10.2353/ajpath.2008.070834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18276782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18276782"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alma Barajas-Espinosa, Fernando Ochoa-Cortes, Michael P Moos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2011.02.041"}], "href": "https://doi.org/10.1016/j.ajpath.2011.02.041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21641390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21641390"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Alma Barajas-Espinosa, Nathan C Ni, Dong Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.11-195792"}], "href": "https://doi.org/10.1096/fj.11-195792"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22131271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22131271"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Michiko K Oyoshi, Rui He, Yoshihide Kanaoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1203127109"}], "href": "https://doi.org/10.1073/pnas.1203127109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22416124"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22416124"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Nora A Barrett, James M Fernandez, Akiko Maekawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1201865"}], "href": "https://doi.org/10.4049/jimmunol.1201865"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23002438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23002438"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wen-Zhen Shi, Chun-Zhen Zhao, Bing Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Bull (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12264-012-1281-z"}], "href": "https://doi.org/10.1007/s12264-012-1281-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23132680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23132680"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hao Wang, Qiaojuan Shi, Wenzhen Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Expression and distribution of cysteinyl leukotriene receptors CysLT1R and CysLT2R, and GPR17 in brain of Parkinson disease model mice]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhejiang Da Xue Xue Bao Yi Xue Ban (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3785/j.issn.1008-9292.2013.01.009"}], "href": "https://doi.org/10.3785/j.issn.1008-9292.2013.01.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23505108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23505108"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hannah E Cummings, Tao Liu, Chunli Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1302187"}], "href": "https://doi.org/10.4049/jimmunol.1302187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24244016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24244016"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Su-Su Tang, Hao Hong, Lan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2013.09.036"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2013.09.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24269024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24269024"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nathan C Ni, Laurel L Ballantyne, Jeffrey D Mewburn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.113.302536"}], "href": "https://doi.org/10.1161/ATVBAHA.113.302536"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24285579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24285579"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tao Liu, Nora A Barrett, Yoshihide Kanaoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1700603"}], "href": "https://doi.org/10.4049/jimmunol.1700603"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29282304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29282304"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Masaya Matsuda, Yuki Tabuchi, Kazuma Nishimura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of CysLT"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " receptors in the lung of asthmatic mice and role in allergic responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostaglandins Leukot Essent Fatty Acids (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.plefa.2018.03.007"}], "href": "https://doi.org/10.1016/j.plefa.2018.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29628047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29628047"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Tao Liu, Nora A Barrett, Yoshihide Kanaoka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mucosal Immunol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41385-019-0134-8"}], "href": "https://doi.org/10.1038/s41385-019-0134-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30664709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30664709"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Tiphaine Voisin, Caroline Perner, Marie-Angele Messou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The CysLT"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "R receptor mediates leukotriene C"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "4"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "-driven acute and chronic itch."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2022087118"}], "href": "https://doi.org/10.1073/pnas.2022087118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33753496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33753496"}]}]}]}
|
| NCBI Gene ID | 100885778 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NALCN-AS1 has 789 functional associations with biological entities spanning 4 categories (disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.
Click the + buttons to view associations for NALCN-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NALCN-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NALCN-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NALCN-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NALCN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NALCN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NALCN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NALCN-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NALCN-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NALCN-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NALCN-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NALCN-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NALCN-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |